ArticleChemSusChem2025
Highly Concentrated Peroxodicarbonate for Efficient Oxidative Degradation of Kraft Lignin.
Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The oxidative degradation of technically relevant types of Kraft lignin is efficiently accomplished by a significantly improved two-step protocol. The key is the use of highly concentrated peroxodicarbonate solution which selectively oxidizes the lignin particles at moderate temperature which are thermally treated in a subsequent step. The liberation of low-molecular-weight phenols occurs when the oxidizer is already consumed enhancing the yield of target compounds strongly up to 15.6 wt%. Co-generated carbonates in this transformation represent the make-up chemical of pulping plants. This makes this approach suitable and attractive to be implemented as a bolt-on or integrated into the Kraft pulping process. The green metrics clearly indicate the sustainable and superior features of the method established.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.